Active · per the CBE, 29 September 2026

SCALE I

BE0675860465

Rechtspersoon Public limited company 1 establishment

Kantersteen 10, 1000 Brussel

Active for

9 year, 4 months

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

  • Busy address KBO

    16 other companies have their registered office at the same address; threshold 10.

  • Not on Peppol Peppol

    Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

SCALE I from Brussel, company number BE0675860465, closed financial year 2025 with a result of € 651,221 after tax. For that financial year SCALE I recorded a gross margin of € -43,828 and equity of € 662,782. Compared with financial year 2024, the result moved from € -293,555 to € 651,221. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 23, 2026.

What it is worth Healthy

€ 662,782

▼ 18% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 651,221

▲ still € 293,555 loss in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 290,987

▲ € 285,940 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 432,782.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 88

Supplier invoices still open on the last day of the fiscal year.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
2022202320242025Change 2024 → 2025
Gross margin € -30,076 € -37,452 € -34,712 € -43,828 ▼ € 9,116
Profit after taxes € -119,625 € -769,472 € -293,555 € 651,221 ▲ € 944,775
Equity € 1,718,926 € 949,454 € 810,899 € 662,782 ▼ 18%
Total debts € 868 € 1,483 € 723 € 281,195 ▲ € 280,472
Cash € 6,765 € 2,254 € 5,048 € 290,987 ▲ € 285,940
Retained profit € 146,689 € -622,783 € -916,338 € 432,782 ▲ € 1.3 million
Bank debt € 0 € 0 € 25 € 0 ▼ 100%
Balance sheet total € 1,719,794 € 950,937 € 811,622 € 943,976 ▲ 16%

Key figures of SCALE I, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to SCALE I?

What happened at SCALE I in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • Hugues WILLIAMSON stepped down as director. NBB
  • Finance & Invest.Brussels SA stepped down as director. NBB
  • 50° North Ventures SA stepped down as director. NBB
  • Sambrinvest Spin-Off / Spin-Out SA stepped down as director. NBB
  • Be Angels Capital SRL stepped down as director. NBB
  • New annual accounts for financial year 2025: profit of € 651,221. Source: NBB ↗
  • Hugues WILLIAMSON became a director. NBB
  • Finance & Invest.Brussels SA became a director. NBB

In short

From € 119,625 loss in 2022 to € 651,221 profit in 2025.

Best year ever: 2025, with € 651,221 profit.

Management

The shares are held by Sambrinvest Spin-Off / Spin-Out SA (30%) and Finance & Invest.Brussels SA (20%). It owns 3.4% of Aquilon Pharmaceuticals itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Hugues WILLIAMSON

Director

Also active at: MAYIO

since 2023 · until 2029

50° North Ventures SA

Director · represented by André OSTACHKOV

Also active at: EEBIC, BE ANGELS, Brussels South Charleroi BioPark Dev, THEODORUS III, THEODIRIS, ALLERINVEST, KABANDY, SEEDER FUND +13 more

since 2023 · until 2029

Be Angels Capital SRL

Director · represented by Claire MUNCK

Also active at: SCALE II

since 2023 · until 2029

Participations

Establishments

Establishment units

Physical locations of this company

Registered office

Kantersteen 10

1000 Brussel

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 16 companies are registered at this address.

All companies at this address →

+11 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0675.860.465
VAT number
BE 0675.860.465
Registered office
Kantersteen 10, 1000 Brussel
Names & denominations
SCALE I
Enterprise type
Rechtspersoon
Legal form
Public limited company
Legal situation
Normale toestand
Start date
19 May 2017
Peppol
Not registered

Frequently asked questions

What is the address of SCALE I?
The registered office of SCALE I is located at Kantersteen 10, 1000 Brussel.
Is SCALE I still active?
Yes. According to the CBE (29 September 2026) SCALE I is active, legal situation “Normale toestand”, started on 19 May 2017.
Is SCALE I registered on Peppol?
No, SCALE I is currently not registered on the Peppol network.
What is the enterprise number of SCALE I?
The enterprise number of SCALE I is BE0675860465.
When was SCALE I founded?
SCALE I was founded on 19 May 2017.
Who owns SCALE I?
The shares are held by Sambrinvest Spin-Off / Spin-Out SA (30%) and Finance & Invest.Brussels SA (20%). It owns 3.4% of Aquilon Pharmaceuticals itself.